These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Evaluation of circulating zonulin as a potential marker in the pathogenesis of nonalcoholic fatty liver disease. Hendy OM; Elsabaawy MM; Aref MM; Khalaf FM; Oda AMA; El Shazly HM APMIS; 2017 Jul; 125(7):607-613. PubMed ID: 28430371 [TBL] [Abstract][Full Text] [Related]
43. Nonalcoholic Fatty Liver Disease and Incident Cardiac Events: The Multi-Ethnic Study of Atherosclerosis. Zeb I; Li D; Budoff MJ; Katz R; Lloyd-Jones D; Agatston A; Blumenthal RS; Blaha MJ; Blankstein R; Carr J; Nasir K J Am Coll Cardiol; 2016 Apr; 67(16):1965-6. PubMed ID: 27102512 [No Abstract] [Full Text] [Related]
44. The Use of Liver Biopsy in Nonalcoholic Fatty Liver Disease: When to Biopsy and in Whom. Gunn NT; Shiffman ML Clin Liver Dis; 2018 Feb; 22(1):109-119. PubMed ID: 29128050 [TBL] [Abstract][Full Text] [Related]
45. Serum Mac-2 binding protein levels as a novel diagnostic biomarker for prediction of disease severity and nonalcoholic steatohepatitis. Kamada Y; Fujii H; Fujii H; Sawai Y; Doi Y; Uozumi N; Mizutani K; Akita M; Sato M; Kida S; Kinoshita N; Maruyama N; Yakushijin T; Miyazaki M; Ezaki H; Hiramatsu N; Yoshida Y; Kiso S; Imai Y; Kawada N; Takehara T; Miyoshi E Proteomics Clin Appl; 2013 Oct; 7(9-10):648-56. PubMed ID: 23775887 [TBL] [Abstract][Full Text] [Related]
47. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Takahashi Y; Fukusato T World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438 [TBL] [Abstract][Full Text] [Related]
48. The management of incidental fatty liver found on imaging. What do we need to do? Méndez-Sánchez N; Chavez-Tapia NC; Almeda-Valdes P; Uribe M Am J Gastroenterol; 2018 Sep; 113(9):1274-1276. PubMed ID: 29549356 [No Abstract] [Full Text] [Related]
49. Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease. Satapathy SK; Sanyal AJ Semin Liver Dis; 2015 Aug; 35(3):221-35. PubMed ID: 26378640 [TBL] [Abstract][Full Text] [Related]
50. Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis. Haga Y; Kanda T; Sasaki R; Nakamura M; Nakamoto S; Yokosuka O World J Gastroenterol; 2015 Dec; 21(46):12989-95. PubMed ID: 26675364 [TBL] [Abstract][Full Text] [Related]
51. Fighting the fatty liver. Drew L Nature; 2017 Oct; 550(7675):S102-S103. PubMed ID: 29019968 [No Abstract] [Full Text] [Related]
52. [An Overview of NAFLD/NASH in Japan]. Kim SR; Kim KI Yakugaku Zasshi; 2016; 136(4):565-72. PubMed ID: 27040340 [TBL] [Abstract][Full Text] [Related]